Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(23)
•••
Comment by YourWifeon Nov 06, 2020 10:56am
177 Views
Post# 31851257

RE:Latest Short Report

RE:Latest Short Report
reziak72 wrote:

Still not split adjusted but up almost 10x two weeks ago

Symbol Issue Name Shares Net Change Date
$SZLS.TO STAGEZERO LIFE SCIENCES LTD. J 681,866 612,963 6 Nov 2020
$SZLS.TO STAGEZERO LIFE SCIENCES LTD. J 68,903 -118,396 21 Oct 2020
$SZLS.TO STAGEZERO LIFE SCIENCES LTD. J 187,299 -383,511 6 Oct 2020
$SZLS.TO STAGEZERO LIFE SCIENCES LTD. J 570,810 -62,850 21 Sep 2020

 

 



Why on earth would you short a stock 1 week prior to Q3 earnings which should be the most profitable quarter of sz history...
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities